Cheng Xiaobao

Clinical focus Benign and malignant kidney tumors and upper urinary tract urothelial tumors, including renal cancer, renal pelvis cancer, ureteral cancer, angiomyolipoma and complex renal cysts; robot-assisted and laparoscopic kidney-sparing surgery. Useful preparation for international patients Cheng Xiaobao is listed in MedToChina's specialist directory for Oncology at The University of Hong Kong-Shenzhen Hospital. For a first case review, patients should prepare a one-page diagnosis and treatment summary, recent test reports with dates and reference ranges, current medications, allergies, and relevant medical history, and pathology or biopsy reports, staging imaging, treatment cycles, radiation summaries, and molecular test reports if available. This profile is most useful for patients who need tumor board-style record review, pathology review preparation, treatment sequence questions, or post-treatment follow-up planning. A short timeline of symptoms, previous treatment, response, side effects, and current goals helps the hospital understand whether the request is suitable for outpatient consultation, inpatient evaluation, second opinion, or further testing. Questions to clarify before booking - Which department should review the case first? - Which records must be translated before the hospital can assess the request? - Are original imaging files, pathology materials, or lab trends needed? - Is the expected visit for consultation only, or could tests or admission be required? - What travel timing is realistic after the hospital reviews the records? Coordination note MedToChina can help organize records, translate core documents, and communicate appointment requirements. Final diagnosis, treatment recommendations, and medical decisions must come from the hospital or licensed physician.